Active	Status	Sponsor type	Region	Phase	Filter
3 Active 24 Inactive 27 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wainstein, Julio
SURMOUNT-MMO, NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity	Active, not recruiting	3	15374	Europe, Canada, Japan, US, RoW	Tirzepatide, LY3298176, Placebo	Eli Lilly and Company	Obesity, Overweight	10/27	10/27
NCT05514548: Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease	Completed	2	265	Europe, Canada, US, RoW	INV-202, None applicable, Placebo	Inversago Pharma Inc., Worldwide Clinical Trials	Diabetic Kidney Disease	08/24	09/24
Jakubowicz, Daniela
Milk-GM, NCT05294861: Effect of Milk Consumption on Glycemia and Gut Microbiome in T2D	Not yet recruiting	N/A	20	NA	YesMdiet, Yes Milk diet, NoMdiet, No Milk diet	Tel Aviv University	Type2Diabetes	10/22	12/22
Boaz, Mona
No trials found